Advertisement

Species and Organ Differences in the Biotransformation of Chemical Carcinogens

  • Mont R. Juchau
Part of the Basic Life Sciences book series

Abstract

Although numerous species and organ differences in the biotransformation of foreign organic chemicals, including chemical carcinogens, have been reported in the literature (for recent reviews see references 1–8), in most instances the studies were not designed for rigorous comparative analyses. Often the differences were noted only as interesting sidelights of a study that did not focus upon precise comparative aspects. Nevertheless, profound differences are known to exist and research on biotransformation in recent years has provided considerable evidence for the existence of numerous species-specific, organ-specific, and cell-specific isozymic forms of the well-known xenobiotic-biotransforming enzymes.

Keywords

Polycyclic Aromatic Hydrocarbon Placental Tissue Polynuclear Aromatic Hydrocarbon Chemical Carcinogenesis Monooxygenase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parke, D.V., and R.L. Smith, eds. 1976. In: Drug Metabolism from Microbe to Man. Taylor and Francis: London. pp. 1–435.Google Scholar
  2. 2.
    Walker, C.H. 1978. Species differences in microsomal monooxygenase activity and their relationship to biological half lives. Drug Metab. Rev. 7: 295–324.PubMedCrossRefGoogle Scholar
  3. 3.
    Kato, R. 1979. Characteristics and differences in the hepatic mixed function oxidases of different species. Pharmac. Ther. 6: 41–98.CrossRefGoogle Scholar
  4. 4.
    Thorgeirsson, S.S., S.A. Atlas, A.R. Boobis, and J.S. Felton. 1979. Species differences in the substrate specificity of hepatic cytochrome P-448 from polycyclic hydrocarbon-treated animals. Biochem. Pharmacol. 28: 217–226.PubMedCrossRefGoogle Scholar
  5. 5.
    Caldwell, J. 1980. Comparative aspects of detoxication in mammals. In: Enzymatic Basis of Detoxication, Volume 1. W.B. Jakoby, ed. Academic Press: New York. pp. 85–116.Google Scholar
  6. 6.
    Gram, T.E., ed. 1980. Extrahepatic Metabolism of Drugs and Other Foreign Compounds. Spectrum Publications: Jamaica, New York. 601 pp.Google Scholar
  7. 7.
    Lu, A.Y.H., and S.B. West. 1980. Multiplicity of mammalian microsomal cytochromes P-450. Pharmacol. Rev. 31: 277–295.Google Scholar
  8. 8.
    Vainio, H.V. 1980. Role of extrahepatic metabolism. In: Concepts in Drug Metabolism, Part A. P. Jenner and B. Testa, eds. Marcel Dekker, Inc.: New York. pp. 251–285.Google Scholar
  9. 9.
    Juchau, M.R., M.G. Pedersen, and K.G. Symms. 1972. Hydroxylation of benzo[a]pyrene in human fetal tissue homogenates. Biochem. Pharmacol. 21: 2269–2272.PubMedCrossRefGoogle Scholar
  10. 10.
    Juchau, M.R., and M.G. Pedersen. 1973. Drug biotransformation reactions in the human fetal adrenal gland. Life Sci. 12: 193–204.CrossRefGoogle Scholar
  11. 11.
    Juchau, M.R., M.J. Namkung, D.L. Berry, and P.K. Zachariah. 1975. Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkey: Correlations with aryl hydrocarbon hydroxylase activities. Drug Metab. Disp. 3: 494–502.Google Scholar
  12. 12.
    Zachariah, P.K., and M.R. Juchau. 1975. Spectral characteristics of human fetal adrenal microsomes. Life Sci. 16: 55–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Berry, D.L., P.K. Zachariah, T.J. Slaga, and M.R. Juchau. 1977. Analysis of the biotransformation of benzo[a]pyrene in human fetal and placental tissues with high pressure liquid chromatography. Eur. J. Cancer 13: 667–675.PubMedCrossRefGoogle Scholar
  14. 14.
    Namkung, M.J., P.K. Zachariah, and M.R. Juchau. 1977. O-Sulfonation of N-hydroxy-2-fluorenylacetamide and 7-hydroxy-N-2-fluorenylacetamide in fetal and placental tissues of humans and guinea pigs. Drug Metab. Disp. 5: 288–294.Google Scholar
  15. 15.
    Jones, A.H., A.G. Fantel, R.M. Kocan, and M.R. Juchau. 1977. Bioactivation of procarcinogens to mutagens in human fetal and placental tissues. Life Sci. 21: 1831–1837.PubMedCrossRefGoogle Scholar
  16. 16.
    Juchau, M.R., M.J. Namkung, A.H.Jones, and J. DiGiovanni. 1978. Biotransformation and bioactivation of 7,12-dimethylbenz[a]anthracene in human fetal and placental tissues. Drug Metab. Disp. 6: 273–281.Google Scholar
  17. 17.
    Juchau, M.R., A.H. Jones, M.J. Namkung, and J. DiGiovanni. 1978. Extrahepatic bioactivation of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in human fetal tissues. In: Carcinogenesis, Volume 3, Polynuclear Aromatic Hydrocarbons. R. Freudenthal and P.W. Jones, eds. Raven Press: New York. pp. 361–370.Google Scholar
  18. 18.
    Juchau, M.R., J. DiGiovanni, M.J. Namkung, and A.H. Jones. 1979. A comparison of the capacity of fetal and adult liver, lung, and brain to convert polycyclic aromatic hydrocarbons to mutagenic and cytotoxic metabolites in mice and rats. Toxicol. Appl. Pharmacol. 49: 171–178.PubMedCrossRefGoogle Scholar
  19. 19.
    Bond, J.A., C.J. Omiecinski, and M.R. Juchau. 1979. Kinetics, activation, and induction of aortic monooxygenases: Analyses of the mixed-function oxidation of benzo[a]pyrene with high-pressure liquid chromatography. Biochem. Pharmacol. 28: 305–312.PubMedCrossRefGoogle Scholar
  20. 20.
    Omiecinski, C.J., J.A. Bond, and M.R. Juchau. 1978. Stimulation by hematin of monooxygenase activity in extrahepatic tissues from rats, rabbits, and chickens. Biochem. Biophys. Res. Comm. 83: 1004–1011.PubMedCrossRefGoogle Scholar
  21. 21.
    Omiecinski, C.J., S.J. Chao, and M.R. Juchau. 1980. Modulation of monooxygenase activities by hematin and 7,8-benzoflavone in fetal tissues of rats, rabbits, and humans. Dev. Pharmacol. Therap. 1: 90–100.Google Scholar
  22. 22.
    Omiecinski, C.J., and M.R. Juchau. 1980. Augmentation by hematin of rates of benzo[a]pyrene hydroxylation: The possible involvement of cytochrome P-450. In: Microsomes, Drug Oxidations, and Chemical Carcinogenesis. M.J. Coon, A.H. Conney, R.W. Estabrook, H.V. Gelboin, J.R. Gillette, and P.J. O’Brien, eds. Academic Press: New York. pp. 969–972.Google Scholar
  23. 23.
    Omiecinski, C.J., M.J. Namkung, and M.R. Juchau. 1980. Mechanistic aspects of the hematin-mediated increases in brain monooxygenase activities. Molec. Pharm. 17: 225–232.Google Scholar
  24. 24.
    Chao, S.T., C.J. Omiecinski, M.J. Namkung, S.D. Nelson, B.H. Dvorchik, and M.R. Juchau. 1981. Catechol estrogen formation in placental and fetal tissues of humans, macaques, rats, and rabbits. Dev. Pharmacol. Therap. 2: 1–17.Google Scholar
  25. 25.
    Omiecinski, C.J., and M.R. Juchau. 1981. Hematin-dependent monooxygenation of benzo[a]pyrene: Positional specificity and DNA binding in vitro. In: Polynuclear Aromatic Hydrocarbons. W.M. Cooke, and A.J. Dennis, eds. Battelle Press: Columbus, Ohio. pp. 697–705.Google Scholar
  26. 26.
    Omiecinski, C.J., M.J. Namkung, and M.R. Juchau. (in press). Substrate and position specificity of hematin-activated monooxygenation reactions. Biochem. Pharmacol.Google Scholar
  27. 27.
    DiGiovanni, J., T.J. Slaga, A. Viaje, D.L. Berry, R.G. Harvey, and M.R. Juchau. 1978. The effects of 7,8-benzoflavone on skin tumor initiating activities of various 7- and 12-substituted derivatives of 7, 12-dimethylbenz[a]anthracene. J. Natl. Cancer Inst. 61: 135–140.PubMedGoogle Scholar
  28. 28.
    Berry, D.L., T.J. Slaga, J. DiGiovanni, and M.R. Juchau. 1979. Studies with chlorinated dibenzo-p-dioxins, polybrominated biphenyls, and polychlorinated biphenyls in a two-stage system of mouse skin carcinogenesis: Potent anticarcinogenic effects. Ann. NY Acad. Sci. 320: 405–415.PubMedGoogle Scholar
  29. 29.
    DiGiovanni, J., D.L. Berry, M.R. Juchau, and T.J. Slaga. 1979. 2,3,7,8-tetrachlorodibenzo-p-dioxin: Potent anticarcinogenic activity. Biochem. Biophys. Res. Comm. 86: 577–584.PubMedCrossRefGoogle Scholar
  30. 30.
    DiGiovanni, J., D.L. Berry, T.J. Slaga, A.H. Jones, and M.R. Juchau. 1979. Effects of pretreatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin on the capacity of hepatic and extrahepatic mouse tissues to convert procarcinogens to mutagens for Salmonella typhimurium auxotrophs. Toxicol. Appl. Pharmacol. 50: 229–239.PubMedCrossRefGoogle Scholar
  31. 31.
    DiGiovanni, J., D.L. Berry, T.J. Slaga, and M.R. Juchau. 1979. Studies on the relationships between induction of biotransformation and tumor-initiating activity of 7–12-dimethylbenz[a]anthracene in mouse skin. In: Polynuclear Aromatic Hydrocarbons. P.W. Jones, and P. Leber, eds. Ann Arbor Science Publishers: Ann Arbor, MI. pp. 553–568.Google Scholar
  32. 32.
    DiGiovanni, J., T.J. Slaga, D.L. Berry, and M.R. Juchau. 1980. Inhibitory effects of environmental chemicals in polycyclic aromatic hydrocarbon carcinogenesis. In: Modifiers of Chemical Carcinogenesis. T.J. Slaga, ed. Raven Press: New York. pp. 145–157.Google Scholar
  33. 33.
    Juchau, M.R., and K.G. Symms. 1972. Aniline hydroxylation in the human placenta-Mechanistic aspects. Biochem. Parmacol. 21: 2053–2065.CrossRefGoogle Scholar
  34. 34.
    Symms, K.G., and M.R. Juchau. 1974. The aniline hydroxylase and nitro-reductase activities of partially purified cytochromes P-450, P-420 and cytochrome b5 solubilized from rabbit hepatic microsomes. Drug Metab. Disp. 2: 194–201.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Mont R. Juchau
    • 1
  1. 1.Department of Pharmacology, School of MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations